中文

The Long View

What the filings say about each company’s story, dilution and cash runway. Updated after each earnings report. Don't see a stock? Request it →

▲ better · ▼ worse · ⚠ watch · ● unchanged, latest quarter · share count · cash

45 companies
Latest quarter Funding
Corcept Therapeutics CORT Self-funding
Xencor XNCR company: into 2029
Arrowhead Pharmaceuticals ARWR company: 12+ months from Nov 2026
Instacart (Maplebear) CART Self-funding
Caterpillar CAT Self-funding
CoStar Group CSGP Self-funding
Fortinet FTNT Self-funding
Genmab GMAB Self-funding
Alphabet GOOGL Self-funding
IDEXX Laboratories IDXX Self-funding
Illumina ILMN Self-funding
Immunocore IMCR company: 12+ months from Nov 2026
Innodata INOD Self-funding
Iovance Biotherapeutics IOVA company: into 2029
Moderna MRNA
Rocket Lab RKLB
Sea Limited SE Self-funding
Tango Therapeutics TNGX company: into 2030
GeneDx Holdings WGS
Agios Pharmaceuticals AGIO
Hims & Hers HIMS Self-funding
TG Therapeutics TGTX Self-funding
Vera Therapeutics VERA
Alnylam Pharmaceuticals ALNY Self-funding
Astera Labs ALAB Self-funding
Gartner IT Self-funding
Madrigal Pharmaceuticals MDGL
Palantir Technologies PLTR Self-funding
Krystal Biotech KRYS Self-funding
Corning GLW Self-funding
Reddit RDDT Self-funding
Credit Acceptance CACC Self-funding
Coinbase COIN Self-funding
ServiceNow NOW Self-funding
Viking Therapeutics VKTX
CATL (Contemporary Amperex Technology) CYATY Self-funding
GE Vernova GEV Self-funding
IG Group IGGHY Self-funding
Pentair PNR Self-funding
Symbotic SYM Self-funding
UniFirst UNF Self-funding
Bloom Energy BE Self-funding
Meta Platforms META Self-funding
Nvidia NVDA Self-funding
ORIC Pharmaceuticals ORIC company: into H2 2028

Signals: the latest quarter, driver by driver (▲ better · ▼ worse · ⚠ watch · ● unchanged). Dilution scale, our rule of thumb: under 1% a year low, 1–3% moderate, over 3% high. Not investment advice.